Moderna Sues Pfizer, BioNTech For mRNA COVID-19 Vaccinations
According to complaints filed by Moderna, Pfizer and BioNTech's COVID-19 vaccine Comirnaty® violates patents the company filed between 2010 and 2016 that protect its...
By 2030, Offshore Formulation Development To Be Worth $60bn
A recent study predicts that the size of the global formulation development outsourcing market will increase from its value of $35.1 billion in 2022...
Pharma Contract Manufacturing Market To Be $130bn By 2026
The global pharmaceutical contract manufacturing market is anticipated to reach $130.2 billion by 2026 as a result of increasing demand for pharmaceuticals, particularly in...
Forecasting Biopharma Contract Manufacturing Trends In 2022
A recent survey found that 86.9% of biopharmaceutical businesses outsource at least a portion of their operations, which has contributed to the $14 billion...
Usual Pharma Compliance Issues Noted In FDA Warning Letters
According to a study of the reasons behind warning letters sent by the US Food and Drug Administration Center for Drug Evaluation and Research and Center for...
CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23
Due to challenges in export sales in the regulated markets and a large base effect in the home formulations sector, the Indian pharmaceutical industry...
US Gives Lynparza Priority Review If Paired With Abiraterone
Priority consideration has been given to AstraZeneca's supplemental new drug application for Lynparza (olaparib) when used in conjunction with abiraterone, prednisone, or prednisolone to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...